Alzheimer's treatments: What's on the horizon? - Mayo Clinic
WEBJul 10, 2024 — The U.S. Food and Drug Administration (FDA) has approved lecanemab (Leqembi) and donanemab (Kisunla) for people with mild Alzheimer's disease and mild cognitive impairment due to Alzheimer's disease. Clinical trials found that the medicines slowed declines in thinking and functioning in people with early Alzheimer's disease.
Dementia Medications: Donepezil, Memantine & More - Healthline
WEBMar 8, 2019 — Several prescription medications are approved by the Food and Drug Administration (FDA) to treat symptoms of dementia caused by AD. These drugs can provide short-term relief from cognitive ...
Alzheimer's: Medicines help manage symptoms and slow decline
WEBJul 10, 2024 — These medicines tend to be most effective for people with early to moderate Alzheimer's disease. If your healthcare professional prescribes medicine as part of an Alzheimer's care plan, make sure you understand the possible benefits and risks.
Lecanemab, the New Alzheimer’s Treatment: 3 Things To Know
WEBJul 24, 2023 — The Food and Drug Administration (FDA) recently granted full approval to a new Alzheimer’s treatment called lecanemab, which has been shown to moderately slow cognitive and functional decline in early-stage cases of the disease.
A new Alzheimer's drug has been approved. But should you take it?
WEBOn June 7, 2021, the FDA granted accelerated approval to aducanumab (brand name Aduhelm), the first drug in 18 years for Alzheimer's disease. Since then the FDA has modified the original language of the approval to recommend that it only be used in certain patients with mild cognitive impairment or early Alzheimer's disease.
Alzheimer’s Disease Medication - WebMD
WEBJul 3, 2024 — Medications for dementia include cholinesterase inhibitors like donepezil and rivastigmine to slow symptom progression, and memantine for moderate to severe cases, aiding memory and daily...
Medications for Memory Loss | Alzheimer's Association
WEBDonepezil (Aricept®): approved to treat all stages of Alzheimer’s disease. Rivastigmine (Exelon®): approved for mild-to-moderate Alzheimer’s as well as mild-to-moderate dementia associated with Parkinson’s disease. Galantamine (Razadyne®): approved for mild-to-moderate stages of Alzheimer’s disease.
A New Alzheimer’s Drug May Be the Most Effective One Yet
WEBJul 2, 2024 — Based on the data provided by the drug's manufacturer, Eli Lilly, for the FDA to review, it’s the most effective drug yet in slowing cognitive decline associated with the disease.
FDA fully approves Leqembi, first drug shown to slow Alzheimer's ...
WEBJul 6, 2023 — In studies reviewed by the FDA, Leqembi appeared to slow declines in memory and thinking by about 27% after 18 months of treatment. It also dramatically reduced the sticky beta-amyloid plaques...
Dementia Treatment: Medication, Therapeutic, and More - Healthline
WEBFeb 17, 2023 — Nowadays, there is a wide variety of medications, therapies, and lifestyle changes that can help treat dementia. Let's look at the pros and cons of each.